Stabilisation : Injectables are delayed until weight has been stable for 3-6 months, when true deficits can be identified and treated conservatively

Concurrent medications that affect potassium balance require consideration: Diuretics (particularly loop and thiazide diuretics) increase renal potassium losses Insulin therapy can shift potassium intracellularly Corticosteroids may promote potassium excretion Laxatives used regularly can contribute to gastrointestinal potassium losses ACE inhibitors, ARBs, and potassium-sparing diuretics (such as spironolactone, eplerenone, amiloride) can increase potassium levels and may complicate management Pre-existing medical conditions may increase susceptibility to electrolyte disturbances: Chronic kidney disease (reduced capacity to regulate potassium) Heart failure (often managed with multiple medications affecting electrolytes) Adrenal insufficiency (impaired aldosterone regulation, typically predisposing to hyperkalaemia) Inflammatory bowel disease (baseline increased gastrointestinal losses) Elderly patients may be at higher risk due to age-related changes in renal function, polypharmacy, and reduced physiological reserve

Many over-the-counter remedies are generally considered safe to use alongside retatrutide, but you should always confirm with your prescribing physician before adding any new medication
Women in perimenopause or menopause Hormonal fluctuations during perimenopause can amplify GI sensitivity and make side effects less predictable
Very compassionate and great vibes from my first visit